The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
Open accessAbstract
Akt is a central regulator of cell growth. Its activity can be negatively regulated by the phosphatase PHLPP that specifically dephosphorylates the hydrophobic motif of Akt (Ser473 in Akt1). However, how PHLPP is targeted to Akt is not clear. Here we show that FKBP51 (FK506-binding protein 51) acts as a scaffolding protein for Akt and PHLPP and promotes dephosphorylation of Akt. Furthermore, FKBP51 is downregulated in pancreatic cancer tissue samples and several cancer cell lines. Decreased FKBP51 expression in cancer cells results in hyperphosphorylation of Akt and decreased cell death following genotoxic stress. Overall, our findings identify FKBP51 as a negative regulator of the Akt pathway, with potentially important implications for cancer etiology and response to chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FKBP51 expression is decreased in several cancer cell lines and in pancreatic cancer tissue, and may correlate with increased Akt phosphorylation and reduced cell sensitivity to chemotherapeutic agents.”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
In the citing paper
“A major advance in mechanistic understanding was the discovery that FKBP51 negatively regulates the activity of the cell growth regulator Akt, by serving as a scaffolding protein to recruit the phosphatase PHLPP [50].”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
In the citing paper
“FKBP51 and FKBP52 likely have a similar activity; however, unlike Pin1, the FKBPs likely coordinate with Hsp90 to isomerize tau [50].”
From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244
Mechanism of activation of protein kinase B by insulin and IGF‐1.
Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 3,014
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,874
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase
Harding, M. W., Gałat, A., Uehling, D., & Schreiber, S. L. (1989) · Nature · doi:10.1038/341758a0 · Cited by 1,396
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
Flagged first, then by citations
1 of the 27 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 727
Ma, Y., Pu, Y., Peng, L. H., Luo, X., Xu, J., Peng, Y., & Tang, X. (2019) · Oncology Letters · doi:10.3892/ol.2019.11042 · Cited by 17
Shi-ying, X., Sun, J., Zhang, Y., Ji, J., & Sun, X. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111754 · Cited by 17
On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart
Lemoine, K. A., Fassas, J. M., Ohannesian, S. H., & Purcell, N. H. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110097 · Cited by 16
Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer
Dong, C., Reiter, J. L., Dong, E., Wang, Y., Lee, K. P., Lu, X., & Liu, Y. (2022) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00124 · Cited by 21
Yang, Y., Ren, L., Li, S., Zheng, X., Liu, J., Wan, L., Fu, W., Wang, J., & Du, G. (2022) · Translational Cancer Research · doi:10.21037/tcr-21-2021 · Cited by 15
Jin, Z., Zhao, L., Chang, Y., Jin, R., Hu, F., Wu, S., Xue, Z., Ma, Y., Chen, C., Zheng, M., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06088-1 · Cited by 16
Post-translational modifications and stress adaptation: the paradigm of FKBP51
Rein, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190332 · Cited by 15
Banaei, N., Moshfegh, J., & Kim, B. G. (2021) · Journal of Raman Spectroscopy · doi:10.1002/jrs.6241 · Cited by 16
Identification and functional analysis of novel oncogene DDX60L in pancreatic ductal adenocarcinoma
Wu, H., Tian, W., Tai, X., Li, X., Li, Z., Shui, J., Yu, J., Wang, Z., & Zhu, X. (2021) · BMC Genomics · doi:10.1186/s12864-021-08137-5 · Cited by 16
From man to mouse and back again: advances in defining tumor AKTivities in vivo
Restuccia, D. F., & Hemmings, B. A. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004671 · Cited by 16
Escoll, P., Ranz, I., Muñoz-Antón, N., Rym, A. M. V. D., Álvarez‐Mon, M., Martínez-Alonso, C., Sanz, E., & de-la-Hera, A. (2015) · Mediators of Inflammation · doi:10.1155/2015/347965 · Cited by 16
Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells
Scott, A. J., Wilkinson, A. S., & Wilkinson, J. C. (2016) · BMC Cancer · doi:10.1186/s12885-016-2320-3 · Cited by 17
The emerging role of FKBP5 in the regulation of metabolism and body weight
Zannas, A. S., Balsevich, G., & Gassen, N. C. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.016 · Cited by 16
Liu, X., Li, T., Huang, X., Wu, W. D., Li, J., Wei, L., Qian, Y., Xu, H., Wang, Q., & Wang, L. (2020) · Oncology Letters · doi:10.3892/ol.2020.12009 · Cited by 15
Self-citationConway, J. R. W., Warren, S. C., Lee, Y.-K., McCulloch, A. T., Magenau, A., Lee, V., Metcalf, X. L., Stoehr, J., Haigh, K., Abdulkhalek, L., et al. (2023) · Science Advances · doi:10.1126/sciadv.adf9063 · Cited by 15
Hanson, R. L., Brown, R. B., Steele, M. M., Grandgenett, P. M., Grunkemeyer, J. A., & Hollingsworth, M. A. (2016) · Oncotarget · doi:10.18632/oncotarget.9557 · Cited by 15
Signaling pathway impact analysis by incorporating the importance and specificity of genes (SPIA-IS)
Fang, H., Li, X., Zan, X., Shen, L., Ma, R., & Liu, W. (2017) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2017.09.009 · Cited by 16
Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer
Liu, S., Cai, Y., Changyong, E., Sheng, J., & Zhang, X. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609868 · Cited by 15
Kandi, R., Gutti, U., Saladi, R. G. V., & Gutti, R. K. (2014) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2014.11.008 · Cited by 15
Similarity of markers identified from cancer gene expression studies: observations from GEO
Shi, X., Shen, S., Liu, J., Huang, J., Zhou, Y., & Ma, S. (2013) · Briefings in Bioinformatics · doi:10.1093/bib/bbt044 · Cited by 15
FK506-binding protein 5 inhibits proliferation and stimulates apoptosis of glioma cells.
Yang, H., Zhang, Q. C., Pei, D., Xu, F., Li, Y., & Yu, R. (2015) · PubMed Central · doi:10.5114/aoms.2015.54864 · Cited by 15
Tosi, A., Santa, S. D., Cappuzzello, E., Marotta, C., Walerych, D., Sal, G. D., Zanovello, P., Sommaggio, R., & Rosato, A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1313371 · Cited by 15
Zhang, Y., Liu, Q., Yang, S., & Liao, Q. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.08.012 · Cited by 14
Saxena, S., Molczyk, C., Purohit, A., Ehrhorn, E. G., Goel, P., Prajapati, D. R., Atri, P., Kaur, S., Grandgenett, P. M., Hollingsworth, M. A., et al. (2022) · PubMed Central · Cited by 14
Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma
Heid, I., Münch, C., Karakaya, S., Lueong, S., Winkelkotte, A. M., Liffers, S. T., Godfrey, L., Cheung, P. F., Savvatakis, K., Topping, G. J., et al. (2022) · Cancer & Metabolism · doi:10.1186/s40170-022-00298-5 · Cited by 14
Kisling, S. G., Atri, P., Shah, A., Cox, J. L., Sharma, S., Smith, L. M., Ghersi, D., & Batra, S. K. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0825 · Cited by 14
Shi, H.-Q., Li, X., Zhou, C., Dong, S., Cheng, Y., Hou, S., Fan, D.-A., Zhang, H., & Zhou, W. (2024) · iScience · doi:10.1016/j.isci.2024.110782 · Cited by 17
Long non‐coding RNAs as key regulators of neurodegenerative protein aggregation
Xu, Q., Liu, D., Zhu, L., Su, Y., & Huang, H. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14498 · Cited by 15
Induction of FKBP51 by aldosterone in intestinal epithelium
Petrovich, E., Asher, C., & Garty, H. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.10.006 · Cited by 14
He, H., Wang, X., Zheng, X., Sun, H., Shi, X.-W., Zhong, Y., Huang, B., Yang, L., Li, J., Liao, L., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.02.011 · Cited by 14
Signalling pathway impact analysis based on the strength of interaction between genes
Bao, Z., Li, X., Zan, X., Shen, L., Ma, R., & Liu, W. (2016) · IET Systems Biology · doi:10.1049/iet-syb.2015.0089 · Cited by 15
Li, H., Liu, X., Jiang, S., Zhou, X., Yao, L., Yang, D., Jiang, Y., Gu, J., Mao, Y., Li, J., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0929-0 · Cited by 14
Shangraw, E. M., Rodrigues, R. O., Choudhary, R. K., Zhao, F., & McFadden, T. B. (2021) · Journal of Dairy Science · doi:10.3168/jds.2020-20048 · Cited by 14
Human FKBP5 Negatively Regulates Transcription through Inhibition of P-TEFb Complex Formation
Mall, D. P., Basu, S., Ghosh, K., Kumari, N., Lahiri, A., Paul, S., & Biswas, D. (2021) · Molecular and Cellular Biology · doi:10.1128/mcb.00344-21 · Cited by 13
Ko, C., Hsieh, Y., & Yang, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126559 · Cited by 14
A Methodological Approach to Unravel Organ-Specific Breast Cancer Metastasis
Nola, S., Sin, S., Bonin, F., Lidereau, R., & Driouch, K. (2012) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-012-9256-2 · Cited by 14
A Novel Pathway Analysis Approach Based on the Unexplained Disregulation of Genes
Ansari, S., Voichiţa, C., Donato, M., Tagett, R., & Drăghici, S. (2016) · Proceedings of the IEEE · doi:10.1109/jproc.2016.2531000 · Cited by 14
Park, J. M., Yang, S. W., Zhuang, W., Bera, A. K., Liu, Y., Gurbani, D., von Hoyningen-Huene, S. J., Sakurada, S. M., Gan, H., Pruett‐Miller, S. M., et al. (2021) · PLoS Biology · doi:10.1371/journal.pbio.3001281 · Cited by 13
FKBP4 regulates 5-fluorouracil sensitivity in colon cancer by controlling mitochondrial respiration
Zhu, Z., Hou, Q., Wang, B., Li, C., Liu, L., Gong, W., Chai, J., Guo, H., & Jia, Y. (2022) · Life Science Alliance · doi:10.26508/lsa.202201413 · Cited by 13
Soto, O. B., Ramirez, C. S., Koyani, R. D., Rodriguez‐Palomares, I. A., Dirmeyer, J. R., Grajeda, B. I., Roy, S., & Cox, M. B. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30406 · Cited by 13
Conformational Dynamics in FKBP Domains: Relevance to Molecular Signaling and Drug Design
LeMaster, D. M., & Hernández, G. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150519113146 · Cited by 13
AmotL2, IQGAP1, and FKBP51 Scaffold Proteins in Glioblastoma Stem Cell Niches
Rotoli, D., Díaz‐Flores, L., Gutiérrez, R., Morales, M., Ávila, J., & Martı́n-Vasallo, P. (2021) · Journal of Histochemistry & Cytochemistry · doi:10.1369/00221554211025480 · Cited by 13
UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer
Feng, L., Wang, Y., Qin, J., Fu, Y., Guo, Z., Zhang, J., He, G., Jiang, Z., Xu, X., Zhou, C., et al. (2021) · BioMed Research International · doi:10.1155/2021/6673125 · Cited by 12
Jiang, C., Wang, M., Yao, W., Lv, G., Liu, X., & Wang, G. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.778857 · Cited by 12
Assessing equivalent and inverse change in genes between diverse experiments
Neums, L., Koestler, D. C., Xia, Q., Hu, J., Patel, S., Bell-Glenn, S., Pei, D., Zhang, B., Boyd, S., Chalise, P., et al. (2022) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2022.893032 · Cited by 12
Jiang, J., Fridley, B. L., Feng, Q., Abo, R., Brisbin, A. G., Batzler, A. J., Jenkins, G. D., Long, P. A., & Wang, L. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00166 · Cited by 13
Self-citationAberrant lactate dehydrogenase A signaling contributes metabolic signatures in pancreatic cancer
Jiang, W., Qiao, L., Zuo, D., Qin, D., Xiao, J., An, H., Wang, Y., Zhang, X., Yu, J. H., & Ren, L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-295 · Cited by 11
Molecular Characterization of Differentiated-Resistance MSC Subclones by Single-Cell Transcriptomes
Stucky, A., Gao, L., Li, S. C., Tu, L., Luo, J., Huang, X., Chen, X., Li, X., Park, T. H., Cai, J., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.699144 · Cited by 12
Zhang, X., Li, X., Xie, J., Zhu, Q., & Yuan, Y. (2022) · Journal of Oncology · doi:10.1155/2022/8909631 · Cited by 12
Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
Zhang, J., Tian, Y., Mo, S., & Fu, X. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 12
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases
Hribal, M. L., Mancuso, E., Spiga, R., Mannino, G. C., Fiorentino, T. V., Andreozzi, F., & Sesti, G. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1130822 · Cited by 12
Paget’s disease of bone: an update on epidemiology, pathogenesis and pharmacotherapy
Gennari, L., Rendina, D., Picchioni, T., Bianciardi, S., Materozzi, M., Nuti, R., & Merlotti, D. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1500691 · Cited by 13
Cheung, C. H. A., Lin, K.-Y., Cheng, S. M., Tsai, S.-L., Tsai, J.-Y., & Lin, C. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s101209 · Cited by 12
Sung, G., Chang, H. K., Lee, J., Song, S. Y., & Kim, H.-S. (2018) · Animal Cells and Systems · doi:10.1080/19768354.2018.1527721 · Cited by 12
Protein Kinase D family kinases
Wille, C., Seufferlein, T. T. W., & Eiseler, T. (2014) · BioArchitecture · doi:10.4161/bioa.29273 · Cited by 11
Li, C., Peng, Z., Wang, Y., Lam, G., Nissen, N. N., Tang, J., Yuan, X., Lewis, M. S., Greene, M. I., Pandol, S. J., et al. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00185.2020 · Cited by 11
Wang, F., Jing, Y., Cheng, C., Cao, Z., Jiao, J., & Chen, Z. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-01043-5 · Cited by 12
Li, Q., Fu, L., Wu, D., & Wang, J. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-613 · Cited by 11
Rocha, S. M., Socorro, S., Passarinha, L. A., & Maia, C. J. (2022) · Data · doi:10.3390/data7050064 · Cited by 11
Wu, T., Qian, T., Lin, R., Jin, D., Xu, X., Huang, M.-X., Ji, J., Jiang, F., Pan, L., Luo, L., et al. (2022) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-22-941 · Cited by 11
Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51
Toneatto, J., Charó, N. L., Galigniana, N. M., & Piwien‐Pilipuk, G. (2015) · Adipocyte · doi:10.1080/21623945.2015.1049401 · Cited by 11
Wang, Y., Song, Z., Leng, P., & Liu, Y. (2019) · Oncology Reports · doi:10.3892/or.2019.7212 · Cited by 11
Understanding the mechanisms of cancers based on function sub-pathways
Liu, W., Xu, P., & Bao, Z. (2018) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.11.011 · Cited by 10
Antascomicin B stabilizes FKBP51-Akt1 complexes as a molecular glue
Schäfer, S. C., Voll, A. M., Bracher, A., Ley, S. V., & Hausch, F. (2024) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2024.129728 · Cited by 10
Михайловна, Ж. Е., Tilova, L. R., Fetisov, T. I., Игоревич, К. К., Kulikov, E. P., Enikeev, A. D., Budunova, I. V., Badun, G. A., Chernysheva, M. G., Ширинян, В. З., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168904 · Cited by 11
The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors
Mazaira, G. I., Lagadari, M., Erlejman, A. G., & Galigniana, M. D. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101094 · Cited by 11
Lyu, M., Gao, W., Zhang, L., Yang, X., Yue, F., Li, H., Ma, X., & Liu, L. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.10.003 · Cited by 10
Andrikou, K., Santoni, M., Piva, F., Bittoni, A., Lanese, A., Pellei, C., Conti, A., Loretelli, C., Mandolesi, A., Giulietti, M., et al. (2015) · Future Oncology · doi:10.2217/fon.15.27 · Cited by 10
Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach
Ma, Y., Hu, J., Zhang, N., Dong, X., Li, Y., Yang, B., Tian, W., & Wang, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149896 · Cited by 10
IQGAP1, AmotL2, and FKBP51 Scaffoldins in the Glioblastoma Microenvironment
Rotoli, D., Morales, M., Maeso, M. D. C., Ávila, J., Pérez-Rodríguez, N. D., Mobasheri, A., Noorden, C. J. F. V., & Martı́n-Vasallo, P. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419833334 · Cited by 10
Chen, Y., Liu, Z., Wang, Y., Zhuang, J., Peng, Y., Mo, X., Chen, J., Shi, Y., Yu, M., Cai, W., et al. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8450 · Cited by 10
Gorjala, P., Goodman, O. B., Kittles, R. A., & Mitra, R. (2020) · Cancers · doi:10.3390/cancers12040989 · Cited by 10
Liu, D., Steins, A., Klaassen, R., van der Zalm, A. P., Bennink, R. J., van Tienhoven, G., Besselink, M. G., Bijlsma, M. F., & van Laarhoven, H. W. M. (2020) · Biomedicines · doi:10.3390/biomedicines8110444 · Cited by 10
Ma, C., Cui, Z., Wang, Y., Zhang, L., Wen, J., Guo, H., Li, N., & Zhang, W. (2020) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2020.5096 · Cited by 10
FK506-binding protein 5 promotes the progression of papillary thyroid carcinoma
Gao, Z., Yu, F., Jia, H., Ye, Z., & Yao, S. (2021) · Journal of International Medical Research · doi:10.1177/03000605211008325 · Cited by 13
Zhang, C., Cui, X., Feng, L., Han, Z., Peng, D., Fu, W., & Xing, Y. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-21-71 · Cited by 10
Zuo, D., Chen, Y., Zhang, X., Wang, Z., Jiang, W., Tang, F., Cheng, R.-F., Sun, Y., Sun, L., Ren, L., et al. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0516 · Cited by 10
Expression profiles analysis of pancreatic cancer.
Yang, D., Zhu, Z., Wang, W., Shen, P., Wei, Z., Wang, C., & Cai, Q. (2013) · PubMed · Cited by 10
Dong, J., Jiao, Y., Mu, W., Lu, B., Wei, M., Sun, L., Hu, S., Cui, B., Liu, X., Chen, Z., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.18903 · Cited by 10
Serine/threonine phosphatase 5 (PP5C/PPP5C) regulates the ISOC channel through a PP5C‐FKBP51 axis
Hamilton, C. L., Abney, K. A., Vasauskas, A. A., ALEXEYEV, M. F., Ni, L., Honkanen, R. E., Scammell, J. G., & Cioffi, D. L. (2017) · Pulmonary Circulation · doi:10.1177/2045893217753156 · Cited by 10
González‐Castrillón, L. M., Wurmser, M., Öhlund, D., & Wilson, S. I. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1181775 · Cited by 9
Du, H.-X., Wang, H., Ma, X., Chen, H., Dai, A.-B., & Zhu, K.-X. (2023) · Oncology Letters · doi:10.3892/ol.2023.14066 · Cited by 9
Li, Y., Chen, M., Li, H., Cai, X.-M., Chen, B., & Xie, Z. (2024) · Open Medicine · doi:10.1515/med-2024-0906 · Cited by 9
Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease
Hill, C., McKnight, A. J., & Smyth, L. J. (2024) · Diabetic Medicine · doi:10.1111/dme.15447 · Cited by 10
Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms
Chung, W.-C., Challagundla, L., Zhou, Y., Li, M., Atfi, A., & Xu, K. (2020) · Life Science Alliance · doi:10.26508/lsa.201900503 · Cited by 9
Alternative splicing of FKBP5 gene exerts control over T lymphocyte expansion
Marrone, L., D’Agostino, M., Cesaro, E., Giacomo, V. D., Urzini, S., Romano, M. F., & Romano, S. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30364 · Cited by 9
Qiu, B., Zhong, Z., Dou, L., Xu, Y., Zou, Y., Weldon, K. S., Wang, J., Zhang, L., Liu, M., Williams, K. E., et al. (2024) · Cell & Bioscience · doi:10.1186/s13578-023-01184-3 · Cited by 10
Yan, X., Zhang, H., Ke, J., Zhang, Y., Dai, C., Zhu, M., Jiang, F., Zhu, H., Zhang, L., Zuo, X., et al. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.53 · Cited by 9
Shi, L., Shang, X. C., Nie, K., Xu, Q., Chen, N., & Zhu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.11921 · Cited by 10
Russ, E. U., Bhuvaneshwar, K., Wang, G., Jin, B., Gage, M. M., Madhavan, S., Gusev, Y., & Upadhyay, G. (2021) · Oncotarget · doi:10.18632/oncotarget.27880 · Cited by 9
Hu, W., Li, M., Wu, J., Chen, H., Zhao, T., Zhang, C., & Wang, Z. (2021) · Oncology Letters · doi:10.3892/ol.2021.13030 · Cited by 9
Emerging roles of PHLPP phosphatases in the nervous system
Mallick, A., Sharma, M., & Dey, C. S. (2022) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2022.103789 · Cited by 9
FK506 binding protein 51: Its role in the adipose organ and beyond
Galigniana, N. M., Ruiz, M. C., & Piwien‐Pilipuk, G. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30351 · Cited by 11
Silencing p110β prevents rapid depletion of nuclear pAkt
Ye, Z., Ghalali, A., Högberg, J., & Stenius, U. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.120 · Cited by 9
Zhao, Y., Zhang, H., Wu, P., Tan, D., Zhao, Y., Zhang, C., Wang, J., Bai, B., An, J., & Shi, C. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b01068 · Cited by 8
Li, S.-L., Zhou, H., Liu, J., Yang, J., Jiang, L., Yuan, H., Wang, M.-H., Yang, K., & Xiang, M. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01300-0 · Cited by 9
Jopek, M. A., Pastuszak, K., Sieczczyński, M., Cygert, S., Zaczek, A. J., Rondina, M. T., & Supernat, A. M. (2024) · Molecular Oncology · doi:10.1002/1878-0261.13689 · Cited by 8
Mitochondrial–nuclear communication by FKBP51 shuttling
Zgajnar, N. R., Lagadari, M., Gallo, L. I., Piwien‐Pilipuk, G., & Galigniana, M. D. (2023) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30386 · Cited by 8
FK506 ‐binding protein 5 regulates cell quiescence‐proliferation decision in zebrafish epithelium
Li, Y., Liu, C., Bai, X., Li, M., & Duan, C. (2023) · FEBS Letters · doi:10.1002/1873-3468.14670 · Cited by 8
Evaluation of the prognostic significances of γ‑secretase genes in pancreatic cancer
Jeon, Y., Ha, M., Kim, S. H., Kim, M. K., Lee, C., Oh, C., Han, M., Oh, S., & Kim, Y. H. (2019) · Oncology Letters · doi:10.3892/ol.2019.10113 · Cited by 8
Metadata
- Authors
- Pei, H., Li, L., Fridley, B. L., Jenkins, G. D., Kalari, K. R., Lingle, W., Petersen, G., Lou, Z., & Wang, L.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Lou, Zhenkun
- Wang, Liewei
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 16
- Issue
- 3
- Pages
- 259-266
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC2755578
- OpenAlex
- W1996667997
- Cited by
- 709
- References
- 27
- Citations by year
- 2026: 23 · 2025: 26 · 2024: 31 · 2023: 44 · 2022: 59 · 2021: 73 · 2020: 63 · 2019: 53 · 2018: 39 · 2017: 48 · 2016: 43 · 2015: 47 · 2014: 48 · 2013: 37 · 2012: 24
- FWCI
- 9.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA102701, P20CA102701, K22CA130828, P50CA102701, R01CA130996, R01CA129344, R01CA138461)
- National Institute of General Medical Sciences (U01GM061388, U19GM061388, GM61388)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- FKBP51, Akt, PHLPP, Akt dephosphorylation, scaffold proteins, pancreatic cancer, chemotherapy response, genotoxic stress, cell death
- MeSH terms
- Docetaxel, Tacrolimus Binding Protein 5, Antimetabolites, Antineoplastic, Antineoplastic Agents, Antineoplastic Agents, Phytogenic, Cell Line, Cytarabine, Drug Therapy, Humans, Kidney, Neoplasms, Nuclear Proteins, Pancreatic Neoplasms, Phosphoprotein Phosphatases, Paclitaxel, Tacrolimus Binding Proteins, Taxoids, Cell Line, Tumor, Proto-Oncogene Proteins c-akt
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review